STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACXP
  4. [8-K] Acurx Pharmaceuticals, Inc. Reports Material Event

[8-K] Acurx Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ACXP logo
Acurx Pharmaceuticals Inc

NASDAQ:ACXP

ACXP Rankings

#9686 Ranked by Market Cap
N/A Ranked by Dividends
#19 Top Loser

ACXP Latest News

Jun 17, 2025
/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./
Jun 17, 2025
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
Jun 17, 2025
Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
Jun 9, 2025
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference
May 13, 2025
Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update

ACXP Latest SEC Filings

Jul 14, 2025
[S-1] Acurx Pharmaceuticals, Inc. Files IPO Registration Statement
Jul 9, 2025
[S-3] Acurx Pharmaceuticals, Inc. Shelf Registration Statement
Jun 27, 2025
[D] Acurx Pharmaceuticals, Inc. SEC Filing
Jun 20, 2025
[8-K] Acurx Pharmaceuticals, Inc. Reports Material Event

ACXP Stock Data

11.74M
20.91M
11.67%
9.8%
2.32%
Biotechnology
Pharmaceutical Preparations
Link
United States
STATEN ISLAND